Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

AIM WINNERS & LOSERS: Jersey Oil in talks with North Sea "heavyweight"

Fri, 31st Mar 2023 11:06

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

----------

AIM - WINNERS

----------

Jersey Oil & Gas PLC, up 33% at 202.5 pence, 12-month range 146p-357p. The upstream oil and gas company updates on the Greater Buchan Area farm-out process, revealing it is in "advanced" exclusive discussions with an unnamed "significant" UK North Sea operator. Says head of terms have been agreed for the farm-out of a material interest in the GBA licenses to the operator, and the parties are working towards a finalised fully-termed agreement "in the near future". They have agreed to an exclusivity period until the end of April. "We are pleased to be in advanced exclusive negotiations with a well-funded industry heavyweight and whilst there can be no guarantees of a successful conclusion, we are aiming to finalise the farm-out in the near future and look forward to updating shareholders shortly," says CEO Andrew Benitz.

----------

AIM - LOSERS

----------

Shearwater Group PLC, down 38% at 51.9p, 12-month range 40p-155p. The cybersecurity group warns its performance in the year ending Friday is likely to disappoint and be "significantly behind market expectations". Expects annual revenue of GBP27.0 million, compared to GBP35.9 million a year before and market consensus of GBP37.7 million. Adjusted earnings before interest, tax, depreciation and amortisation are expected at "around breakeven", compared to market consensus that it would remain unchanged from the GBP4.4 million achieved in the prior year. The weaker performance reflects delays in finalisation of orders in Services and Software businesses, as customers defer investment decisions or implement spending freezes amid market volatility in the final quarter. "Looking forward the group retains a strong pipeline on which to deliver sustainable revenue, with profits moving forward as we deliver deals to our loyal customer base, including banks and telecoms businesses," Shearwater says.

----------

Asimilar Group PLC, down 33% at 1.40p, 12-month range 1.3p-30p. The technology investor says it will suspend its shares from trading on AIM and AQSE from Monday, as it will fail to meet the reporting deadline for its audited annual results for the year ended September 30. "The board has been working hard with the auditor to clear all outstanding issues, however, the auditor requires additional time to complete all audit formalities," it says. The delay is partly due to an "exhaustive" review process of independent third-party valuations on some of the firm's unquoted investee companies.

----------

Emis Group PLC, down 24% at 1,376p, 12-month range 1,242p-1,918p. The healthcare software firm falls on news that the UK competition watchdog has referred its acquisition by US healthcare insurer UnitedHealth to a phase 2 investigation. Earlier this month, as part of its phase 1 probe, the UK Competition & Markets Authority found competition in the fields of population health management and medicines optimisation software would be hurt by the deal. Both Emis and UnitedHealth-owned Optum Health Solutions (UK) provide software services to GPs in the UK. In response, UnitedHealth proposed a remedy to divest of Optum's Medicines Optimisation and Population Health Management businesses in the UK. The CMA rejected the remedy, and confirmed it would refer the acquisition for a phase 2 investigation. Emis and UnitedHealth say they are "disappointed" with the decision, believing the divestment would directly address the CMA's competition concerns.

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

Related Shares

More News
30 Oct 2023 10:40

Emis shares cancelled upon GBP1.2 billion UnitedHealth takeover

(Alliance News) - Emis Group PLC shares were cancelled from trading on AIM on Monday, after its takeover by UnitedHealth Group Inc subsidiary Optum He...

27 Oct 2023 13:00

IN BRIEF: Emis to suspend shares as takeover becomes effective

Emis Group PLC - Leeds, England-based healthcare software and services - Shares suspended from trading on AIM in London on Friday and expects to cance...

16 Oct 2023 15:46

UK dividends calendar - next 7 days

29 Sep 2023 11:05

UK CMA clears UnitedHealth acquisition of Emis following investigation

(Alliance News) - Emis Group PLC on Friday said the UK Competition & Markets Authority cleared its acquisition by UnitedHealth Group Inc to proceed.

29 Sep 2023 09:38

UK's CMA clears UnitedHealth's £1.2bn takeover of EMIS

(Sharecast News) - The Competition and Markets Authority said on Friday that it has cleared UnitedHealth's proposed £1.2bn takeover of UK ...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.